Welgene Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	190.71	173.5	188.13	158.59	199.77	160.34
Short-Term Investments	63	53	9	59	21	21
Trading Asset Securities	-	-	-	-	2.72	-
Cash & Short-Term Investments	253.71	226.5	197.13	217.59	223.49	181.34
Cash Growth	26.04%	14.90%	-9.40%	-2.64%	23.24%	-5.70%
Accounts Receivable	47.58	45.58	46.98	46.57	82.86	61.81
Other Receivables	0.9	3.61	3.24	0.75	4.28	1.15
Receivables	48.49	49.19	50.23	47.31	87.14	62.96
Inventory	38.2	36.88	53.77	33.98	26.99	18.37
Prepaid Expenses	6.6	5.96	4.45	2.46	2.74	1.68
Other Current Assets	2.01	1.7	0.71	0.86	0.77	0.77
Total Current Assets	349	320.22	306.28	302.2	341.13	265.12
Property, Plant & Equipment	172.91	174.88	198.82	78.63	30.67	44.03
Long-Term Investments	24.48	26.12	33.98	42.09	41.36	39.37
Other Intangible Assets	0.72	0.16	0.39	0.73	1.07	1.41
Long-Term Deferred Tax Assets	0.5	0.44	0.56	0.49	0.69	0.67
Other Long-Term Assets	6.96	6.42	8.13	11.57	9.62	9.69
Total Assets	554.58	528.25	548.16	435.71	424.54	360.29
Accounts Payable	21.6	16.91	17.37	18.99	12.53	15.45
Accrued Expenses	17.72	24.28	21.18	25.02	26.61	29.29
Short-Term Debt	13	9	11	11.21	12.56	7
Current Portion of Long-Term Debt	22.72	11.68	11.05	-	-	-
Current Portion of Leases	2.95	13.58	13.33	13.08	11.28	11.1
Current Income Taxes Payable	-	0.36	-	2.44	-	3.48
Current Unearned Revenue	50.83	56.13	46.18	29.45	46.53	23.43
Other Current Liabilities	4.65	4.66	7.84	4.51	4.71	6.24
Total Current Liabilities	133.46	136.59	127.94	104.71	114.22	95.98
Long-Term Debt	127.3	95.58	105.4	-	-	-
Long-Term Leases	-	-	13.58	26.9	-	11.28
Pension & Post-Retirement Benefits	-	-	-	0.12	0.24	0.28
Long-Term Deferred Tax Liabilities	0.34	0.32	0.3	0.03	0.02	-
Other Long-Term Liabilities	0.02	0.02	0.68	-	-	-
Total Liabilities	261.11	232.5	247.89	131.76	114.47	107.54
Common Stock	233.04	233.04	233.04	233.04	233.04	207.04
Additional Paid-In Capital	50.93	50.86	50.86	50.86	50.86	6.52
Retained Earnings	21.94	20.62	19.51	27.18	28.88	40.88
Comprehensive Income & Other	-17.1	-16.61	-11.38	-7.32	-2.92	-1.9
Total Common Equity	288.82	287.91	292.03	303.76	309.86	252.54
Minority Interest	4.64	7.84	8.24	0.2	0.21	0.21
Shareholders' Equity	293.47	295.75	300.27	303.95	310.06	252.74
Total Liabilities & Equity	554.58	528.25	548.16	435.71	424.54	360.29
Total Debt	165.97	129.83	154.35	51.19	23.84	29.38
Net Cash (Debt)	87.75	96.66	42.78	166.4	199.64	151.96
Net Cash Growth	37.76%	125.94%	-74.29%	-16.65%	31.38%	2.68%
Net Cash Per Share	3.77	4.15	1.84	7.13	8.64	7.30
Filing Date Shares Outstanding	23.3	23.3	23.3	23.3	23.3	20.7
Total Common Shares Outstanding	23.3	23.3	23.3	23.3	23.3	20.7
Working Capital	215.54	183.63	178.34	197.49	226.92	169.14
Book Value Per Share	12.39	12.35	12.53	13.03	13.30	12.20
Tangible Book Value	288.1	287.75	291.64	303.03	308.79	251.12
Tangible Book Value Per Share	12.36	12.35	12.51	13.00	13.25	12.13
Land	22.76	22.76	22.76	-	-	-
Buildings	97.7	97.7	97.7	-	-	-
Machinery	103.39	93.49	107.46	77.2	55.9	54.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.